Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-21-020434

Executive Vice President & CFO acquired 87,719 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Konidaris Tasos Executive Vice President & CFO 2021-03-12 Option exercise +87,719 87,719 D
Derivatives
Konidaris Tasos Executive Vice President & CFO 2021-03-12 Option exercise · Restricted Stock Units −87,719 263,158 D
Loading xslF345X03/doc4.xml…